| Revision as of 09:51, 28 August 2011 editBogBot (talk | contribs)Bots53,132 edits populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot← Previous edit |
Latest revision as of 00:26, 23 January 2023 edit undoEntranced98 (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers172,972 edits Importing Wikidata short description: "Chemical compound"Tag: Shortdesc helper |
| (16 intermediate revisions by 10 users not shown) |
| Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Unreferenced stub|auto=yes|date=December 2009}} |
|
|
{{Drugbox |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
| ⚫ |
| verifiedrevid = 443652033 |
|
|
|
| Watchedfields = changed |
| ⚫ |
| IUPAC_name = (''RS'')-''2-(2-oxopyrrolidin-1-yl)butanamide'' |
|
|
⚫ |
| verifiedrevid = 447116863 |
|
⚫ |
| IUPAC_name = (''RS'')-2-(2-Oxopyrrolidin-1-yl)butanamide |
|
| image = Etiracetam structure.svg |
|
| image = Etiracetam structure.svg |
|
| width = 106px |
|
| width = 106px |
|
| image2 = Etiracetam3d.png |
|
| image2 = Etiracetam3d.png |
|
| imagename = 1 : 1 mixture (racemate) |
|
| chirality = ] |
|
⚫ |
<!-- Clinical data --> |
|
| drug_name = Etiracetam |
|
|
|
|
| ⚫ |
<!--Clinical data--> |
|
|
| tradename = |
|
| tradename = |
|
| pregnancy_category = |
|
| pregnancy_category = |
|
| legal_status = Unscheduled (US) |
|
| legal_status = |
|
|
| legal_US = Unscheduled |
|
| routes_of_administration = Oral |
|
| routes_of_administration = Oral |
|
⚫ |
<!-- Pharmacokinetic data --> |
|
|
|
| ⚫ |
<!--Pharmacokinetic data--> |
|
|
| bioavailability = |
|
| bioavailability = |
|
| metabolism = |
|
| metabolism = |
|
| excretion = |
|
| excretion = |
|
⚫ |
<!-- Identifiers --> |
|
|
|
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
| ⚫ |
<!--Identifiers--> |
|
|
| CAS_number = 33996-58-6 |
|
| CAS_number = 33996-58-6 |
|
| ATC_prefix = none |
|
| ATC_prefix = none |
| Line 27: |
Line 27: |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 53863 |
|
| ChemSpiderID = 53863 |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 1400561 |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
| UNII = 230447L0GL |
|
| UNII = 230447L0GL |
|
⚫ |
<!-- Chemical data --> |
|
|
|
|
⚫ |
| C=8 | H=14 | N=2 | O=2 |
| ⚫ |
<!--Chemical data--> |
|
| ⚫ |
| C=8 | H=14 | N=2 | O=2 |
|
|
| molecular_weight = 170.209 g/mol |
|
|
| smiles = CCC(C(=O)N)N1CCCC1=O |
|
| smiles = CCC(C(=O)N)N1CCCC1=O |
|
| InChI = 1/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) |
|
|
| InChIKey = HPHUVLMMVZITSG-UHFFFAOYAH |
|
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) |
|
| StdInChI = 1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) |
| Line 41: |
Line 39: |
|
| StdInChIKey = HPHUVLMMVZITSG-UHFFFAOYSA-N |
|
| StdInChIKey = HPHUVLMMVZITSG-UHFFFAOYSA-N |
|
}} |
|
}} |
|
'''Etiracetam''' is a ] ] of the ] family. It is ]; its biologically active ]ic form is ]. |
|
'''Etiracetam''' is a chemical compound belonging to the ] family, which was developed as a ] drug. It is ]; its biologically active ]ic form is ], now marketed as an ].<ref>{{cite journal | vauthors = Sara SJ | title = Memory retrieval deficits: alleviation by etiracetam, a nootropic drug | journal = Psychopharmacology | volume = 68 | issue = 3 | pages = 235–41 | year = 1980 | pmid = 6771807 | doi = 10.1007/bf00428109 | s2cid = 23369972 }}</ref> |
|
|
|
|
|
==See also== |
|
== See also == |
|
*] |
|
*] |
|
|
|
|
|
== References == |
|
|
{{reflist}} |
|
|
|
|
|
{{Racetams}} |
|
{{Racetams}} |
|
|
|
|
|
] |
|
] |
|
] |
|
] |
|
] |
|
|
|
|
|
|
|
|
|
{{nervous-system-drug-stub}} |
|
{{nervous-system-drug-stub}} |